Sonendo (SONX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
After losing some value lately, a hammer chart pattern has been formed for Sonendo (SONX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Sonendo, Inc. (OTCQX:SONX) Q2 2024 Earnings Conference Call August 7, 2024 4:30 PM ET Corporate Participants Louisa Smith - IR, Gilmartin Group Bjarne Bergheim - President and Chief Executive Officer John Bostjancic - Chief Financial Officer Conference Call Participants Joe Federico - Stifel Financial Corporation Operator Good afternoon, and welcome to the Sonendo Second Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
| Software Industry | Information Technology Sector | Mr. Bjarne Bergheim CEO | OTC PINK Exchange | US8354311073 ISIN |
| US Country | 200 Employees | - Last Dividend | - Last Split | 29 Oct 2021 IPO Date |
Sonendo, Inc. stands out as a pioneering medical technology firm primarily focused on the realm of dentistry, specifically advancing root canal therapy in the North American market—encompassing both the United States and Canada. This transformation from the original Dentatek Corporation, a name change that took place in March 2011, marks a significant pivot in their mission to revolutionize dental care. The entity, established in 2006 and rooted in Laguna Hills, California, operates at the commercial stage, dedicating itself to the design, production, and commercial distribution of innovative dental devices.